DOCS
NEUTRALDr. Martens Directors Increase Shareholdings
The retailer has announced that two of its directors have increased their shareholdings in the company through a share purchase scheme.
Dr. Martens
91.20GBX
1.16%
Market Cap
898.76M
Volume
956.83k
84% of avg
P/E Ratio
16.43
EPS (TTM)
5.55
Beta
0.23
Day Range
87.95p - 92.86p
52 Week Range
43.02p91.20p96.50p
91.20p
Upcoming Events
DOCS
NEUTRALDr. Martens Announces Change in Shareholding
The retailer has announced a change in shareholding, with Artemis Investment Management LLP increasing its stake in the company.
DOCS
NEUTRALDr. Martens Announces Director/PCA Shareholding Changes
The retailer announces changes to shareholdings by its Chief Financial Officer and a Person Closely Associated.
DOCS
NEUTRALDr. Martens Directors Increase Shareholdings
The footwear retailer has announced that two of its directors have increased their shareholdings in the company through the employee share scheme.
DOCS
NEUTRALDr. Martens Announces Director/PDMR Share Purchases
The retailer has announced share purchases by its directors and senior managers under the company's bonus scheme.
DOCS
NEUTRALDr. Martens Directors Increase Shareholdings
The retailer has announced that two of its directors have increased their shareholdings in the company through the employee share incentive plan.
DOCS
NEUTRALDr. Martens Provides AGM Trading Update: Trading in Line with Expectations
The retailer provides a trading update, reporting mixed performance across regions but overall trading in line with expectations.
DOCS
NEUTRALDr. Martens Grants Performance Share Awards to Executives
The retailer has granted performance share awards to its top executives under the company's long-term incentive plan.
DOCS
NEUTRALDr. Martens Publishes 2025 Annual Report
The retailer has published its 2025 Annual Report and Notice of Annual General Meeting, providing shareholders with the latest financial information and details on the upcoming AGM.
DOCS
NEUTRALDr. Martens Directors Increase Shareholdings
The retailer's directors have increased their shareholdings in the company through a share purchase scheme.